Chromatin/Epigenetics - Immunological Diseases - Prostate Cancer
Epigenetics is the heritable modifications in gene expression that is not associated with changes in DNA sequence. Epigenetic modifications occur mostly on DNA or on the histone octamer. There are several types of epigenetics modifications, DNA methylation by DNA-methyl transferase (DNMT) and covalent modification of histones (e.g. acetylation, methylation, phosphorylation and ubiquitination). Histone acetylation by histone acetyltransferases (HATs) is involved in transcriptional activation, whereas histone deacetylation by histone deacetylases (HDACs) is connected with transcriptional repression. Histone demethylation is associated with lysine-specific demethylase (LSD) and JmjC domain containing histone demethylase (JHDM).
The nucleosome is consisted of four histone proteins (H2A, H2B, H3, and H4), they are primary building block of chromatin. The addition and removal of specific chemical groups refers to as epigenetic marks, it regulates chromatin structure and affects gene expression. Moreover, RNA is intimately involved in the formation of a repressive chromatin state.
Epigenetic mechanism responds to environmental changes at the cellular level and thus influences cellular plasticity. Chromatin and epigenetic regulation play a significant role in the programming of the genome during development and stress response, defects in epigenetics can lead to cancer, inflammation and metabolic disorders etc.
- B4890 HPOB1 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC6抑制剂
- B1577 C6461 CitationTarget: p300Summary: HAT p300-CBP抑制剂
- A1912 Lomeguatrib中文名: 罗米鲁曲Target: O6-methylguanine-DNA-methyl-transferase (MGMT)Summary: MGMT抑制剂
- A4118 Hesperadin1 Citation中文名: 橙皮甙,橙皮苷Target: Aurora KinasesSummary: Aurora B抑制剂
- A4104 AR-42 (OSU-HDAC42)2 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC抑制剂
- A4096 Belinostat (PXD101)2 Citation中文名: 贝利司他Target: Histone Deacetylases (HDACs)Summary: 羟肟酸型HDAC抑制剂
- A4138 Tofacitinib (CP-690550,Tasocitinib)1 Citation中文名: 托法替尼,托法替布Target: JAKSummary: Janus激酶抑制剂
- A4090 JNJ-264815853 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC抑制剂
- A4084 Vorinostat (SAHA, MK0683)9 Citation中文名: 伏立诺他Target: Histone Deacetylases (HDACs)Summary: HDAC抑制剂
- A3012 Ruxolitinib (INCB018424)4 Citation中文名: 鲁索替尼Target: JAKSummary: JAK抑制剂